A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
Applying to Beth Israel Deaconess Medical Center / BIDMC VCRS (Site ID: 32077) · Boston, Massachusetts
Answer a few short questions to share with the research team.